The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology
- Earn up to 39 CME credits | ABIM
Media Formats Choose Video Option:Online – $1,895Online + USB – $2,045Online + USB + Printed Syllabus – $2,270
Starting at$1,895.00Current Stock:
Quick Facts
a CMEinfo video production
Accredited by:Oakstone Publishing
Content by:Brigham and Women’s Hospital and
Dana-Farber Cancer Institute
Course Directors:
Maureen M. Achebe, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Clinical Director
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Nancy Berliner, MD
Professor of Medicine
Harvard Medical School
Chief, Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Wendy Y. Chen, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Credits:Earn a maximum of 39 AMA PRA Category 1 Credits™ and 39 ABIM MOC points
Overview
Essential Hematology and Oncology CME
The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online video CME program focused on improving overall knowledge and clinical competency with comprehensive updates on basic principles, changing guidelines, and therapeutic strategies. Continuing medical education areas for practice improvement include:
- Hematopoiesis and Cytokines
- Platelet Disorders
- Molecular Genetics of Cancer
- New Therapies (Pharmacology)
- Palliative Care (Management of Symptoms/End of Life)
- Gastrointestinal Cancers (Neuroendocrine/Esophageal/Pancreas/Colorectal)
- Thoracic Oncology (Head/Neck/Lung/Thyroid)
- and many more…
Interested in the individual Brigham and Dana-Farber hematology or oncology program instead? You’ll find the hematology CME course here, and the oncology CME course here.
Topics / Speakers
Molecular Genetics of Cancer – Marios Giannakis, MD, PhD
Infections in Cancer Patients – Lindsey Baden, MD
Opioid Prescribing for Cancer-Related Pain – Kate M. Lally, MD
Communication – The Key to Excellence in End-of-Life Care – Eilann C. Santo, MD, MPH
Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
Biology of Acute Leukemia and Myelodysplastic Syndromes – Zuzana Tothova, MD, PhD
The Evolving Treatment Landscape of the Acute Leukemias – Where Are We Now – Daniel J. DeAngelo, MD, PhD
Myelodysplastic Syndrome – Eric S. Winer, MD
Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
Myeloproliferative Syndromes – Joan-Chi How, MD
Multiple Myeloma – Kenneth C. Anderson, MD
Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD
Low Grade Lymphomas – Caron A. Jacobson, MD
Non-Hodgkin’s Lymphona – Diffuse Large B-Cell and Burkitt – Eric D. Jacobsen, MD
Non-Hodgkin Lymphoma – Mantle Cell and T-Cell – Eric D. Jacobsen, MD
Hodgkin’s Lymphoma – Reid W. Merryman, MD
Diagnosis and Treatment of CLL and Related B-Cell Malignancies – Matthew S. Davids, MD
Head and Neck Cancer – Kartik Sehgal, MD
Thyroid Cancer – Kartik Sehgal, MD
Natural History, Screening, and Small Cell Lung Cancer – Jacob M. Sands, MD
Management of Stage I-III – Non Small Cell Lung Cancer – Julia Rotow, MD
Management of Metastatic – Non Small Cell Lung Cancer – Julia Rotow, MD
Mesothelioma and Thymic Malignancies – David Kwiatkowski, MD, PhD
Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD
Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD
Pancreatic Cancer – Brian M. Wolpin, MD
Hepatobiliary Cancers Board Review – James M. Cleary, MD, PhD
Management of Localized Colorectal Cancer – Douglas A. Rubinson, MD, PhD
Metastatic Colorectal Cancer – Leah H. Biller, MD
Gastrointestinal Cancer Genetics – Asaf Maoz, MD
Prostate, Bladder, and Testicular Cancer – Mark M. Pomerantz, MD
Key Updates in Urothelial Carcinoma – Bradley A. McGregor, MD
Key Updates in Renal Cell Carcinoma – Bradley A. McGregor, MD
Prostate Cancer Part I – Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD
Prostate Cancer Part II – Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD
Melanoma – F. Stephen Hodi, MD
Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD
Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD
Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
Neuro-oncology – David A. Reardon, MD
Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
Multimodality Therapy for Early Stage Breast Cancer – Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
Multimodality Therapy for Early Stage Breast Cancer – Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
Management of Metastatic Breast Cancer – Adrienne G. Waks, MD
Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
Hematopoiesis and Cytokines – David B. Sykes, MD, PhD
Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
Congenital Bone Marrow Failure – Grant Rowe, MD, PhD
HLH – Sarah Nikiforow, MD
Anemia – An Overview – Robert Stern, MD
Iron Deficiency and Iron Overload – Mark D. Fleming, MD, Dphil
Immune Hemolytic Anemia – Arielle L. Langer, MD, MPH
Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
Sickle Cell Disease – Maureen M. Achebe, MD, MPH
Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
Disorders of Neutrophils – Nancy Berliner, MD
Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
Hemophilia – Stacy E. Croteau, MD
Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
Managing Challenging Cases of Venous Thrombosis in Patients with Cancer – Jean M. Connors, MD
Transfusion Medicine for the Clinician – Marie A. Hollenhorst, MD, PhD
Faculty
Course Directors
Maureen M. Achebe, MD, MPH – Hematology
Associate Professor of Medicine
Harvard Medical School
Clinical Director
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Nancy Berliner, MD – Hematology
Professor of Medicine
Harvard Medical School
Chief, Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Wendy Y. Chen, MD – Oncology
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Faculty
Kenneth C. Anderson, MD
Kraft Family Professor of Medicine
Harvard Medical School
Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Lindsey Baden, MD
Elizabeth G. and Gary J. Nabel Family Professor
Professor of Medicine
Harvard Medical School
Director Immunocompromised Service
Division of Infectious Diseases
Department of Medicine
Brigham and Women’s Hospital
Elisabeth M. Battinelli, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Kenneth A. Bauer, MD
Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Beth Israel Deaconess Medical Center
Leah H. Biller, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Harold J. Burstein, MD, PhD
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Jorge J. Castillo, MD
Associate Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Jennifer Ang Chan, MD
Associate Professor of Medicine
Harvard Medical School
Director, Program in Neuroendocrine and Carcinoid Tumors
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Atish D. Choudhury, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
James M. Cleary, MD, PhD
Associate Professor of Medicine
Harvard Medical School
Director, Clinical Research,
Division of Gastrointestinal Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Nathan T. Connell, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Division of Hematology
Vice Chair, Department of Medicine
Brigham and Women’s Hospital
Jean M. Connors, MD
Associate Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Stacy E. Croteau, MD
Professor of Pediatrics
Harvard Medical School
Dana-Farber Cancer Institute
Department of Cancer and Blood Disorders Center
Boston Children’s Hospital
Matthew S. Davids, MD
Associate Professor of Medicine
Harvard Medical School
Clinical Research Director
Division of Lymphoma
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Daniel J. DeAngelo, MD, PhD
Professor of Medicine
Harvard Medical School
Chief of the Division of Leukemia
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Peter C. Enzinger, MD
Associate Professor of Medicine
Harvard Medical School
Director, Center for Esophageal and Gastric Cancer
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Mark D. Fleming, MD, PhD
S. Burt Wolbach Professor of Pathology
Harvard Medical School
Department of Pathology
Boston Children’s Hospital
Judy E. Garber, MD, MPH
Professor of Medicine
Harvard Medical School
Chief, Division of Cancer Genetics and Prevention
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Suzanne George, MD
Associate Professor of Medicine
Harvard Medical School
Chief, Division of Sarcoma
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Marios Giannakis, MD, PhD
Associate Professor of Medicine
Harvard Medical School
Department of Medical Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
David E. Golan, PhD, MD
Professor of Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Matthew M. Heeney, MD
Associate Professor of Pediatrics
Harvard Medical School
Dana-Farber Cancer Institute
Division of Hematology
Department of Medicine
Boston Children’s Hospital
F. Stephen Hodi, MD
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Marie A. Hollenhorst, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Joan-Chi How, MD
Assistant Professor of Medicine
Harvard Medical School
Chief of Hematology
Brigham and Women’s Faulkner Hospital
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Eric D. Jacobsen, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director
Adult Lymphoma Program and Institute Physician
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Caron A. Jacobson, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Panagiotis A. Konstantinopoulos, MD, PhD
Associate Professor of Medicine
Harvard Medical School
Director Translational Research Gynecologic Oncology Program
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
David Kwiatkowski, MD, PhD
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Kate M. Lally, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director, Adult Palliative Care
Department of Psychosocial Oncology and Palliative Care
Dana-Farber Cancer Institute
Division of Palliative Medicine
Department of Medicine
Brigham and Women’s Hospital
Arielle L. Langer, MD, MPH
Assistant Professor of Medicine
Harvard Medical School
Director, Thalassemia Program
Director, Women’s Bleeding and Clotting Disorders Program
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
Julie-Aurore Losman, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Marlise R. Luskin, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Asaf Maoz, MD
Instructor in Medicine
Harvard Medical School
Division of Genetics and Prevention and Gastrointestinal Cancer Center
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Ursula A. Matulonis, MD
Professor of Medicine
Harvard Medical School
Chief, Division of Gynecologic Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Bradley A. McGregor, MD
Professor of Medicine
Harvard Medical School
Director of Clinical Research
Lank Center for GU Oncology
Marra Lochiatto Investigatorship in Kidney Cancer Research
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Reid W. Merryman, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Sarah Nikiforow, MD
Assistant Professor of Medicine
Harvard Medical School
Medical Director
Cell Manipulation Core Facility
Technical Director
Immune Effector Cell Program
Stem Cell Transplantation Clinician
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Ann H. Partridge, MD, MPH
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Mark M. Pomerantz, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
David A. Reardon, MD
Professor of Medicine
Harvard Medical School
Clinical Director
Center for Neuro-Oncology and Alperin Family Chair in Neuro-Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Julia Rotow, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director
Lowe Center for Thoracic Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Grant Rowe, MD, PhD
Assistant Professor of Pediatrics
Harvard Medical School
Director, BMF Clinic
Department of Hematology/Oncology
Boston Children’s Hospital
Blood Disorders Center
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Douglas A. Rubinson, MD, PhD
Assistant Professor of Medicine
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Jacob M. Sands, MD
Assistant Professor of Medicine
Harvard Medical School
Thoracic Oncology Program
Dana-Farber Cancer Institute
Eilann C. Santo, MD, MPH
Instructor in Medicine
Harvard Medical School
Psychosocial Oncology and Palliative Care
Medical Director, HeartPal
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Kartik Sehgal, MD
Instructor of Medicine
Harvard Medical School
Director of Clinical Research
Head and Neck Oncology
Director, Thyroid Cancer Center
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Robert J. Soiffer, MD
Worthington and Margaret Collette
Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Chief, Division of Hematologic Malignancies
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Robert Stern, MD
Assistant Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Brigham and Women’s Hospital
David B. Sykes, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Division of Hematology
Department of Medicine
Massachusetts General Hospital
Zuzana Tothova, MD, PhD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Adrienne G. Waks, MD
Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Eric S. Winer, MD
Assistant Professor of Medicine
Harvard Medical School
Clinical Director, Division of Adult Leukemia
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Brian M. Wolpin, MD
Professor of Medicine
Harvard Medical School
Director, Gastrointestinal Cancer Center
Director, Hale Family Center for Pancreatic Cancer
Robert T. & Judith B. Hale Chair in Pancreatic Cancer
Department of Medical Oncology
Dana-Farber Cancer Institute
Department of Medicine
Brigham and Women’s Hospital
Accreditation / Pass Guarantee
Accreditation
Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
Oakstone Publishing designates this enduring material for a maximum of 39 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 39 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Date of Original Release: March 15, 2025
Termination Date: March 14, 2028
CME credit is awarded upon successful completion of a course evaluation and post-test.
Learning Objectives
At the conclusion of this activity, the participant will be able to:
- Apply current/recommended hematology and oncology guidelines in clinical practice
- Perform differential diagnosis of complex clinical presentations related to hematologic and oncologic disorders
- Identify/apply current therapeutic options for specific hematologic and oncologic disorders
- Review and interpret up-to-date literature relevant to clinical practice in hematology and oncology
- Demonstrate knowledge of pathophysiology as it applies to management of hematology and oncology disorders
- Apply knowledge gained to the ABIM certification/recertification hematology and oncology examinations
Intended Audience
The activity was planned for fellows/trainees, practicing hematology and oncology specialists (MDs), and other professional affiliates (internists with an interest in hematology and oncology) who are preparing to take ABIM board review or recertification examinations, or who seek CME activities to improve patient care in the areas of hematology and oncology medicine.
Board Pass Guarantee
We’re Committed to Your Success. Oakstone stands behind the quality of its board review programs. If you complete a course and do not pass your board examination, we will provide extended access to the content or credit toward the purchase of a future board review program in accordance with our CME Board Pass Guarantee policy.
This pass guarantee is a product policy offered by Oakstone and is independent of CME accreditation. Accreditation pertains only to the educational activity and does not guarantee examination outcomes.
SKU: HEX559E0
About Oakstone
About Ebix
Ebix | Oakstone Publishing
1 Ebix Way
Johns Creek, GA 30097
Copyright © 2026 Ebix Inc. Terms of Service | Privacy Policy | Sitemap